HCPCS Code Descriptor:
Injection, talimogene laherparepvec, per 1 million plaque forming units
Route of Administration:
IMLYGIC is an Oncology drug manufactured by Amgen and administered via the Injection route of administration. The J Code: J9325 is aligned to the drug IMLYGIC.